๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

I.P15 The predictive value of olfactory dysfunction and cognitive dysfunction for preclinical Parkinson's Disease

โœ Scribed by M.M. Ponsen; D. Stoffers; E.Ch. Wolters; H.W. Berendse

Book ID
117752186
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
58 KB
Volume
12
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The olfactory and cognitive deficits of
The olfactory and cognitive deficits of parkinson's disease: Evidence for independence
โœ Richard L. Doty; Manuel Riklan; Daniel A. Deems; Constance Reynolds; Stanley Ste ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 656 KB

In the present study we sought to determine whether the olfactory deficits of parkinsonism are related to the cognitive and perceptual-motor manifestations of the disease. Pearson correlation coefficients were computed among a number of olfactory, neurologicai, and neuropsychological measures obtain

Atomoxetine for the treatment of executi
Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open-label study
โœ Laura Marsh; Kevin Biglan; Melissa Gerstenhaber; James R. Williams ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 321 KB ๐Ÿ‘ 1 views

## Abstract Executive dysfunction (ED) is a prominent and often disabling feature of cognitive impairment in Parkinson's disease (PD). Few studies have examined treatments. Given the role of noradrenergic pathology in ED, atomoxetine, a norepinephrine reuptake inhibitor indicated for attention defi